[go: up one dir, main page]

WO2001023416A3 - Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof - Google Patents

Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof Download PDF

Info

Publication number
WO2001023416A3
WO2001023416A3 PCT/EP2000/009495 EP0009495W WO0123416A3 WO 2001023416 A3 WO2001023416 A3 WO 2001023416A3 EP 0009495 W EP0009495 W EP 0009495W WO 0123416 A3 WO0123416 A3 WO 0123416A3
Authority
WO
WIPO (PCT)
Prior art keywords
immunogenic polypeptide
polypeptide derived
moraxella catarrhalis
polypeptides
basb132
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2000/009495
Other languages
French (fr)
Other versions
WO2001023416A2 (en
Inventor
Joelle Thonnard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Priority to JP2001526566A priority Critical patent/JP2003511013A/en
Priority to EP00967819A priority patent/EP1216302A2/en
Priority to HK02108464.8A priority patent/HK1046931A1/en
Priority to CA002386077A priority patent/CA2386077A1/en
Priority to AU77846/00A priority patent/AU7784600A/en
Publication of WO2001023416A2 publication Critical patent/WO2001023416A2/en
Publication of WO2001023416A3 publication Critical patent/WO2001023416A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention provides BASB132 polypeptides and polynucleotides encoding BASB132 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
PCT/EP2000/009495 1999-09-30 2000-09-26 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof Ceased WO2001023416A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2001526566A JP2003511013A (en) 1999-09-30 2000-09-26 BASB132 polypeptides and polynucleotides from Moraxella catarrhalis
EP00967819A EP1216302A2 (en) 1999-09-30 2000-09-26 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof
HK02108464.8A HK1046931A1 (en) 1999-09-30 2000-09-26 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof
CA002386077A CA2386077A1 (en) 1999-09-30 2000-09-26 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof
AU77846/00A AU7784600A (en) 1999-09-30 2000-09-26 Novel compounds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9923156.5A GB9923156D0 (en) 1999-09-30 1999-09-30 Novel compounds
GB9923156.5 1999-09-30

Publications (2)

Publication Number Publication Date
WO2001023416A2 WO2001023416A2 (en) 2001-04-05
WO2001023416A3 true WO2001023416A3 (en) 2001-08-16

Family

ID=10861896

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/009495 Ceased WO2001023416A2 (en) 1999-09-30 2000-09-26 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof

Country Status (8)

Country Link
EP (1) EP1216302A2 (en)
JP (1) JP2003511013A (en)
CN (1) CN1402785A (en)
AU (1) AU7784600A (en)
CA (1) CA2386077A1 (en)
GB (1) GB9923156D0 (en)
HK (1) HK1046931A1 (en)
WO (1) WO2001023416A2 (en)

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE SWISSPROT 1 January 1900 (1900-01-01), FLEISCHMANN R. D., ET AL.: "HYPOTHETICAL PROTEIN HI0696", XP002162427, Database accession no. Q57523 *
FLEISCHMANN, R.D. ET AL.: "Whole-Genome Random Sequenceing and Assembly of Haemophilus influenza Rd", SCIENCE, vol. 269, no. 5223, 28 July 1995 (1995-07-28), pages 496 - 512, XP000517090 *
MYERS, L.E. ET AL.: "The Transferrin Binding Protein B of Moraxella catarrhalis Elicits Bactericidal Antibodies and Is a Potential Vaccine Antigen", INFECTION AND IMMUNITY, vol. 66, no. 9, September 1998 (1998-09-01), pages 4183 - 4192, XP002118475 *

Also Published As

Publication number Publication date
AU7784600A (en) 2001-04-30
CN1402785A (en) 2003-03-12
HK1046931A1 (en) 2003-01-30
CA2386077A1 (en) 2001-04-05
WO2001023416A2 (en) 2001-04-05
GB9923156D0 (en) 1999-12-01
EP1216302A2 (en) 2002-06-26
JP2003511013A (en) 2003-03-25

Similar Documents

Publication Publication Date Title
WO1999058562A3 (en) Novel compounds
WO1999058684A3 (en) Compounds from moraxella catarrhalis
WO1999057277A3 (en) Basb019 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
WO1999064602A3 (en) Moraxella catarrhalis polynucleotides and polypeptides
WO2000071724A3 (en) Novel compounds from moraxella catarrhalis
WO1999064448A3 (en) Moraxella catarrhalis pilq proteins
PL345193A1 (en) Basb027 proteins and genes from moraxella catarrhalis
WO2001009332A3 (en) Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof
HK1047956A1 (en) Basb118 polypeptide and polynucleotide from moraxella catarrhalis
WO2001009333A3 (en) Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof
WO2002034768A3 (en) Polypeptides and polynucleodides from haemophilus influenzae and their use
HK1047943A1 (en) Moraxella cattarrhalis basb114 antigens and uses thereof
WO2001023416A3 (en) Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof
WO2001009172A3 (en) Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof
WO2002030960A3 (en) Polypeptide from haemophilus influenza
AU6988700A (en) Basb119 polypeptide and polynucleotide from moraxella catarrhalis
WO1999058682A3 (en) Compounds from moraxella catarrhalis
WO2001009339A3 (en) Moraxella catarrhalis antigen basb117
WO2001009331A3 (en) Moraxella catarrhalis antigen basb125
WO2001019997A3 (en) BASB128 polypeptide and polynucleotide from moxarella catarrhalis
WO1999058685A3 (en) Basb028 polypeptides and polynucleotides encoding therefor from moraxella catarrhalis
WO2001009337A3 (en) Moraxella catarrhalis antigens basb122 and basb124
WO2001019862A3 (en) Polypeptides from moraxella (branhamella) catarrhalis
WO2001009330A3 (en) Moraxella catarrhalis antigen basb121
WO2001009335A3 (en) Moraxella catarrhalis antigen basb120

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2000967819

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2386077

Country of ref document: CA

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 526566

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 008165017

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 2000967819

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000967819

Country of ref document: EP